title: Severity of imported malaria: protective effect of taking malaria chemoprophylaxis.
abstract: BACKGROUND
  Although chemoprophylaxis remains an important strategy for preventing malaria in travellers, its effectiveness may be compromised by lack of adherence. Inappropriate use of chemoprophylaxis is likely to increase the risk of acquiring malaria, but may probably also worsen the severity of imported cases. The aim of this study was to assess the impact of use of malaria chemoprophylaxis on clinical features and outcome of imported malaria.
  
  
  METHODS
  Demographic, clinical and laboratory data of patients included in the Rotterdam Malaria Cohort between 1998 and 2011 were systematically collected and analysed. Patients were classified as self-reported compliant or non-compliant users or as non-users of chemoprophylaxis. Severe malaria was defined using the 2010 WHO criteria.
  
  
  RESULTS
  Details on chemoprophylaxis were available for 559 of the 604 patients, of which 64.6% were non-users, 17.9% were inadequate users and 17.5% reported to be adequate users. The group of non-users was predominated by patients with African ethnicity, partial immunity and people visiting friends and relatives. The majority contracted Plasmodium falciparum malaria. In contrast, compliant users acquired non-falciparum malaria more frequently, had significant lower P. falciparum loads on admission, shorter duration of hospitalization and significant lower odds for severe malaria as compared with non-users. Patients with P. falciparum malaria were more likely to have taken their chemoprophylaxis less compliantly than those infected with non-P. falciparum species. Multivariate analysis showed that self-reported adequate prophylaxis and being a partially immune traveller visiting friends and relatives was associated with significantly lower odds ratio of severe malaria. In contrast, age, acquisition of malaria in West-Africa and being a non-immune tourist increased their risk significantly.
  
  
  CONCLUSIONS
  Compliant use of malaria chemoprophylaxis was associated with significantly lower odds ratios for severe malaria as compared with non-compliant users and non-users of chemoprophylaxis. After correction for age, gender and immunity, this protective effect of malaria chemoprophylaxis was present only in individuals who adhered compliantly to use of chemoprophylaxis. Patients with P. falciparum malaria were more likely to have used their chemoprophylaxis less compliantly than patients with non-P. falciparum malaria who were more likely to have contracted malaria in spite of compliant use of chemoprophylaxis.
authors.affiliation: Institute for Tropical Diseases, Harbour Hospital, Haringvliet 72, Rotterdam, The Netherlands.
authors.forename: Klaske
authors.initials: K
authors.lastname: Vliegenthart-Jongbloed
authors.forename: Mariana
authors.initials: M
authors.lastname: de Mendonça Melo
authors.forename: Marlies E
authors.initials: ME
authors.lastname: van Wolfswinkel
authors.forename: Rob
authors.initials: R
authors.lastname: Koelewijn
authors.forename: Jaap J
authors.initials: JJ
authors.lastname: van Hellemond
authors.forename: Perry J J
authors.initials: PJ
authors.lastname: van Genderen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D063426:Human Migration; D006801:Humans; D016778:Malaria, Falciparum / Q000473:pathology* / Q000517:prevention & control*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D009426:Netherlands; D014195:Travel; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000962:Antimalarials
references.citation: N Engl J Med. 2003 Oct 16;349(16):1496-8
references.pmid: 14561790
references.citation: Am J Trop Med Hyg. 2006 Dec;75(6):1188-94
references.pmid: 17172391
references.citation: Emerg Infect Dis. 2005 Mar;11(3):436-41
references.pmid: 15757560
references.citation: Clin Infect Dis. 2009 Apr 1;48(7):871-8
references.pmid: 19243243
references.citation: Expert Opin Drug Saf. 2002 May;1(1):19-27
references.pmid: 12904156
references.citation: Am J Trop Med Hyg. 2007 Feb;76(2):208-23
references.pmid: 17297027
references.citation: J Travel Med. 2010 Jul-Aug;17(4):217-20
references.pmid: 20636593
references.citation: BMJ. 2012 Mar 27;344:e2116
references.pmid: 22454091
references.citation: Emerg Infect Dis. 2011 May;17(5):807-13
references.pmid: 21529388
references.citation: Trans R Soc Trop Med Hyg. 2004 Jan;98(1):55-63
references.pmid: 14702838
references.citation: J Travel Med. 2005 Sep-Oct;12(5):261-4
references.pmid: 16256049
references.citation: Trop Med Int Health. 1997 Jul;2(7):705-13
references.pmid: 9270740
references.citation: Malar J. 2010 May 25;9:140
references.pmid: 20497587
references.citation: J Clin Psychiatry. 2005 Feb;66(2):199-204
references.pmid: 15705005
references.citation: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006491
references.pmid: 19821371
references.citation: Lancet. 1986 Jul 26;2(8500):229
references.pmid: 2873482
references.citation: Malar J. 2012 May 29;11:179
references.pmid: 22642661
references.citation: Transfusion. 2010 Apr;50(4):787-94
references.pmid: 19951317
references.citation: Am J Trop Med Hyg. 2011 Apr;84(4):517-31
references.pmid: 21460003
references.citation: BMJ. 1992 Sep 26;305(6856):741-3
references.pmid: 1422328
references.citation: PLoS One. 2010 Oct 08;5(10):e13236
references.pmid: 20949045
references.citation: J Travel Med. 1998 Jun;5(2):92-4
references.pmid: 9772323
references.citation: Clin Infect Dis. 2001 Oct 1;33(7):1015-21
references.pmid: 11528574
references.citation: Malar J. 2010 Dec 09;9:357
references.pmid: 21143906
references.citation: Cochrane Database Syst Rev. 2000;(4):CD000138
references.pmid: 11034675